<DOC>
	<DOCNO>NCT00003833</DOCNO>
	<brief_summary>RATIONALE : Genetic study may help understand genetic process cause type cancer . PURPOSE : Genetic trial study certain gene patient stage II stage III colon cancer .</brief_summary>
	<brief_title>Genetic Study Patients With Stage II Stage III Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine adverse prognostic significance 8p allelic imbalance ( AI ) patient colon cancer . - Determine patient prognosis dependent region 8p AI . - Perform fine mapping study localize putative tumor suppressor gene ( ) 8p . - Perform multicolor FISH examine role 8p loss 8q gain play prognosis patient whose tumor exhibit 8p AI . OUTLINE : Matched normal tumor DNA analyze 8p allelic imbalance least 8 marker : D8S262 D8S1825 localize 8p23 , D8S254 D8S261 8p22 , D8S560 D8S136 8p21 , D8S1820 D8S283 8p12 . Normal/tumor tissue pair use fine mapping study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis resectable stage II III adenocarcinoma colon Participated NCCTG914653 DNA extract normal tumor tissue PATIENT CHARACTERISTICS : Age Under 70</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
</DOC>